Century Therapeutics, Inc.IPSCNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +1457.09% | +12667.72% | -100.00% | -100.00% | -100.00% |
| Gross Profit Growth | +0.00% | +12667.72% | -515.18% | -495.58% | -185.07% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +31.34% | +38.08% | +5.05% | +2.08% | +10.05% |
| Weighted Average Shares Diluted Growth | +31.34% | +38.21% | +5.05% | +2.08% | +10.05% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +128.57% | +0.00% | +0.00% | -64.12% | -56.12% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -2.07% | -9.44% | -31.64% | -37.03% | -36.67% |
| Book Value per Share Growth | -33.50% | -2.11% | -10.04% | -11.72% | -10.50% |
| Debt Growth | +11.75% | +13.36% | -8.68% | -17.66% | -19.07% |
| R&D Expense Growth | +26.09% | +13.49% | -13.09% | -28.76% | -32.93% |
| SG&A Expenses Growth | -9.71% | -3.83% | -10.64% | -21.02% | -87.69% |